The US blood plasma market is expanding due to increasing demand for plasma-derived therapies, rising prevalence of chronic and immune-related disorders, and growing need for immunoglobulins and other plasma-based products. Increased plasma collection activities, investments in plasma donation infrastructure, and advancements in plasma fractionation are supporting market growth. Growing...